Koligo Therapeutics (ASX:KOL) FCF Margin %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Koligo Therapeutics FCF Margin %?

Koligo Therapeutics ASX:KOL FCF Margin % is 0.00% as of . 20.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Koligo Therapeutics's Free Cash Flow for the six months ended in . 20 was A$0.00 Mil. Koligo Therapeutics's Revenue for the six months ended in . 20 was A$0.00 Mil. Therefore, Koligo Therapeutics's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Koligo Therapeutics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Koligo Therapeutics's FCF Margin % or its related term are showing as below:


ASX:KOL's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.535
* Ranked among companies with meaningful FCF Margin % only.

Koligo Therapeutics FCF Margin % Related Terms

Koligo Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics FCF Margin % Chart

Koligo Therapeutics Annual Data
Trend
FCF Margin %

Koligo Therapeutics Semi-Annual Data
FCF Margin %

ASX:KOL vs : FCF Margin % Comparison

For the Biotechnology subindustry, Koligo Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Koligo Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Koligo Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Koligo Therapeutics's FCF Margin % falls into.


Koligo Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Koligo Therapeutics's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Koligo Therapeutics's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Koligo Therapeutics (ASX:KOL) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Koligo Therapeutics and its competitors.
Is Koligo Therapeutics' FCF Margin % too high?
Koligo Therapeutics' current FCF Margin % is 0.00%.
How does Koligo Therapeutics' FCF Margin % compare to ?
Koligo Therapeutics' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Koligo Therapeutics and its competitors. Koligo Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies